News
Article
Top 10 BPH articles and videos of 2024
Author(s):
Key Takeaways
- Studies reveal a connection between benign prostatic hyperplasia and erectile dysfunction, emphasizing the need for comprehensive patient management.
- Aquablation therapy receives a Category I CPT code and FDA clearance for an AI-powered robotic system, enhancing its clinical application.
As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.
There has been a lot of news about benign prostatic hyperplasia (BPH) over the past year. To celebrate these breakthroughs, the editorial staff at Urology Times® are showcasing our best content on BPH from 2024.
Olivia Paulsen on the association between BPH and erectile dysfunction
In this video, Olivia Paulsen gives an overview of the study “Benign Prostatic Enlargement Is Associated With Erectile Dysfunction in United States,” which she presented at the 25th Fall Scientific Meeting of the Sexual Medicine Society of North in Scottsdale, Arizona. Watch the video here
Investigators compare costs for surgical treatments of BPH
In this video, Kevin M. Wymer, MD, shares the background and notable findings from the recent Urology paper “Evaluation of Private Payer and Patient Out of Pocket Costs Associated with the Surgical Management of Benign Prostatic Hyperplasia.” Watch the video here
Erectile and ejaculatory function preserved with Optilume BPH Catheter System
Treatment of lower urinary tract symptoms (LUTS) secondary to BPH with the Optilume BPH Catheter System appears to preserve erectile and ejaculatory function in addition to providing relief from LUTS, according to a study presented at the 2024 American Urological Association Annual Meeting in San Antonio, Texas. Read more here
Urologist discusses Aquablation, rise in large prostates seen in his practice
In this video, Joseph Song, MD, discusses Aquablation and shares an observation regarding an increase in large prostates. Watch the video here
Aquablation granted new category I CPT code for BPH management
The American Medical Association has granted a Category I Current Procedural Terminology (CPT) code to Aquablation for the management of BPH, thus replacing the therapy’s existing Category III CPT code. Learn more here
FDA grants 510(k) clearance to AI-powered robotic system for Aquablation therapy
The FDA has granted 510(k) clearance to the HYDROS robotic system, an AI-powered platform designed to enhance the delivery of Aquablation therapy for patients with BPH, PROCEPT BioRobotics, the developer of the platform, announced in a news release. Read more here
Phase 1/2 trial launches of Focal One robotic HIFU for BPH
The first patients have been treated in a phase 1/2 study (NCT06601179) evaluating the safety and efficacy of Focal One robotic high-intensity focused ultrasound in the treatment of patients with BPH, EDAP TMS SA announced in a news release. Learn more here
Study of ProVee System for BPH hits enrollment goal
The target enrollment has been met in the ProVIDE trial (NCT05186740), which is evaluating the safety and efficacy of the ProVee System, a stent-like urethral expander for the treatment of patients with lower urinary tract symptoms secondary to BPH, announced ProVerum, the developer of the therapy, in a news release. Read more here
Dr. Sterling and Dr. Friel describe initial experience, patient selection for Aquablation for BPH
In this interview, Matthew E. Sterling, MD, and Brian Friel, MD, discuss the Aquablation procedure for the treatment of BPH, including how the procedure works, what patient selection is like, and what advice they would give other providers just starting out with Aquablation. Learn more here
Real-world data support safety, efficacy of Aquablation for BPH-related LUTS
Data from a post-market survey presented at the Japanese Urological Association Annual Meeting support the safety and efficacy of Aquablation therapy in men in Japan with lower urinary tract symptoms due to BPH. Read more here
